Jaguar Gene Therapy Presents Preclinical Data of JAG101 in Type 1 Galactosemia at American Society of Gene and Cell Therapy 25th Annual Meeting - Yahoo Finance

LAKE FOREST, Ill., May 16, 2022--Jaguar Gene Therapy today announced results of two preclinical studies of JAG101 in two different animal models of Type 1...

- Preclinical studies support continued development of JAG101, an investigational gene therapy designed to address the root cause of Type 1 galactosemia and reduce multiple toxic metabolites - Precl… [+9054 chars]

full article...